Cancer Treatments Linked to Aggravated Insomnia
the Cancer Therapy Advisor take:
Insomnia symptoms become intensified by cancer treatments and their side effects, according to a study published online in the journal Cancer.
In a longitudinal study involving 465 patients with breast cancer and 263 patients with prostate cancer, Insomnia Severity Index (ISI) and somatic symptoms were assessed at baseline and 2, 6, 10, 14, and 18 months later.
Results showed that patients with breast cancer who underwent radiotherapy and chemotherapy experienced an increased insomnia severity, but those who underwent hormone therapy did not. In patients with prostate cancer, androgen deprivation therapy was also associated with increased insomnia.
A variety of somatic symptoms were found to significantly mediate the effects of chemotherapy and radiotherapy on insomnia in patients with breast cancer.
Furthermore, night sweats were determined to have a significant mediating role for hormone therapy in patients with breast cancer and patients with prostate cancer.
The study suggests that side effects of cancer treatments be more closely monitored and managed in order to prevent the aggravation of insomnia symptoms in patients.
Insomnia symptoms become intensified by cancer treatments and their side effects.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Metastatic Prostate Cancer Responds to Novel Radiation Therapy
- Clinical Applications of Liquid Biopsies in Cancer
- Two-Drug Combination Superior to Sunitinib in Patients With Untreated Advanced Renal Cell Carcinoma
- Radical Prostatectomy Compared With Watchful Waiting in Localized Prostate Cancer
- Immunotherapy in Glioblastoma: Peaks and Pits
- OS and PFS End Points Not Met in Phase 3 Trial of Pembrolizumab in Advanced HCC
- No Benefit Observed With Osimertinib Plus Durvalumab in EGFR-Mutated NSCLC
- Evidence of the Role of Circulating Insulin on Renal Cell Carcinoma Risk
- Treatment Guidelines in Cancer: Assessing Industry Influence on Recommendations
- American Society of Breast Surgeons Recommends Genetic Testing for All Patients With Breast Cancer